Early-stage funding slumps toward post-pandemic low, piling more pressure on biotech startups Read more →
FDA advisory committee set to weigh taking action on certain unapproved peptides Read more →
Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen Read more →
« All Events
February 5, 2025 @ 8:30 am
The agenda at BioInfect will focus on the issues surrounding the increasing threat of AMR and how it can be addressed.